IOVA Stock-Based Compensation
Iovance Biotherapeutics Inc · Stock-Based Compensation
IOVA Stock-Based Compensation
Latest reported$46.72Mperiod ending
IOVA Stock-Based Comp ($0.00 → $46.72M)
Annual stock-based compensation
High-resolution chart · PNG
IOVA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 61,575,000 | |
| 109,627,000 | |
| 62,625,000 | |
| 84,022,000 | |
| 69,765,000 | |
| 40,887,000 | |
| 24,277,000 | |
| 20,027,000 | |
| 11,968,000 | |
| 18,904,000 | |
| 8,523,000 | |
| 3,814,000 | |
| 19,680,000 | |
| 3,328,254 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |